1-13 of 13
Yingtong Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Ping Yang, Chunyuan Li, Jinjie Gao, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 6339.
https://doi.org/10.1182/blood-2024-205068
Published: 2024
Journal Articles

Treatment Outcomes of BTK Inhibitors and Venetoclax with/without Anti-CD20 Monoclonal Antibody in Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Real-World Experience

Ping Yang, Chunyuan Li, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 6338.
https://doi.org/10.1182/blood-2024-205042
Published: 2024
Journal Articles

Central Nervous System Involvement in Mantle Cell Lymphoma: Clinical Features, Prognostic Factors and Outcomes from Multi-Centers in China

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Weilong Zhang, Jing Wang, Yingtong Chen, Xiaoyu Hao, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 6337.
https://doi.org/10.1182/blood-2024-204938
Published: 2024
Journal Articles

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Ping Yang, Chunyuan Li, Shuozi Liu, Yuan Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 6305.
https://doi.org/10.1182/blood-2024-205002
Published: 2024
Journal Articles

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 6303.
https://doi.org/10.1182/blood-2024-204939
Published: 2024
Journal Articles

TP53 Mutation Heterogeneity Reveals Distinct Prognoses in Mantle Cell Lymphoma

Shuozi Liu, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Ping Yang, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 6301.
https://doi.org/10.1182/blood-2024-204877
Published: 2024
Journal Articles

Targeting p53 Improves Drug Resistance in Mantle Cell Lymphoma By Regulating Mitophagy-Dependent Ferroptosis

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 5836.
https://doi.org/10.1182/blood-2024-205447
Published: 2024
Journal Articles

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 5845.
https://doi.org/10.1182/blood-2024-205492
Published: 2024
Journal Articles

UHRF1 Is a Promising Therapy Target in Aggressive Mantle Cell Lymphoma

Yuan Yang, Ping Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Chunyuan Li, Hongmei Jing
Journal: Blood
Blood (2024) 144 (Supplement 1): 5753.
https://doi.org/10.1182/blood-2024-204870
Published: 2024
Journal Articles

1q21+ Is Associated with Poor Prognosis in Newly Diagnosed Multiple Myeloma Patients with Extramedullary Disease: A Retrospective Study

Shuang Gao, Fei Dong, Ping Yang, Yingtong Chen, Yanfang Wang, Jing Wang, Hongmei Jing
Journal: Blood
Blood (2023) 142 (Supplement 1): 6685.
https://doi.org/10.1182/blood-2023-184339
Published: 2023
Journal Articles

The Efficacy of Obinutuzumab Combined with Pomalidomide and Covalent Btki for the Treatment of TP53 Mutated Mantle Cell Lymphoma (MCL): A Prospective, Open-Label, Single-Arm Study

Ping Yang, Shuozi Liu, Weilong Zhang, Jing Wang, Yingtong Chen, Hongmei Jing
Journal: Blood
Blood (2023) 142 (Supplement 1): 3049.
https://doi.org/10.1182/blood-2023-184372
Published: 2023
Journal Articles

Inhibition of CDC20 Suppressed the Development and Progression of Mantle Cell Lymphoma

Yingtong Chen, Ping Yang, Jing Wang, Shuang Gao, Xiaoyan Ke, Hongmei Jing
Journal: Blood
Blood (2023) 142 (Supplement 1): 4416.
https://doi.org/10.1182/blood-2023-183096
Published: 2023
Journal Articles

Genetic and Prognostic Analysis in Blastoid and Pleomorphic Mantle Cell Lymphoma: A Multicenter Analysis in China

Ping Yang, Shuozi Liu, Chunyuan Li, Weilong Zhang, Jing Wang, Yingtong Chen, Sen Li, Cuiling Liu, Hui Liu, Qingqing Cai, Wei Zhang, Hongmei Jing
Journal: Blood
Blood (2022) 140 (Supplement 1): 11907–11908.
https://doi.org/10.1182/blood-2022-165107
Published: 2022